High level of phosphatidylcholines/lysophosphatidylcholine ratio in urine is associated with prostate cancer-Reference-Cited by-同舟云学术

High level of phosphatidylcholines/lysophosphatidylcholine ratio in urine is associated with prostate cancer

Published:2021-08-19 Issue:10 Volume:112 Page:4292-4302
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Li Xin¹,Nakayama Kenji¹,Goto Takayuki¹,Kimura Hiroko¹^ORCID,Akamatsu Shusuke¹,Hayashi Yujiro²^ORCID,Fujita Kazutoshi²³,Kobayashi Takashi¹^ORCID,Shimizu Koji⁴,Nonomura Norio²^ORCID,Ogawa Osamu¹,Inoue Takahiro⁵^ORCID

Affiliation:

1. Department of Urology Graduate School of Medicine Kyoto University Kyoto Japan

2. Department of Urology Osaka University Graduate School of Medicine Suita Japan

3. Department of Urology Kindai University Faculty of MedicineHigashi‐Osaka Japan

4. Clinical Research Center for Medical Equipment Development Kyoto University Hospital Kyoto Japan

5. Department of Nephro‐Urologic Surgery and Andrology Mie University Graduate School of Medicine Tsu Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15093

Reference46 articles.

1. Lipid pathway deregulation in advanced prostate cancer

2. The Metabolic Landscape of Prostate Cancer

3. Lipids and prostate cancer

4. A narrative review of urinary phospholipids: from biochemical aspect towards clinical application

5. Effect of d-allose on prostate cancer cell lines: phospholipid profiling by nanoflow liquid chromatography–tandem mass spectrometry

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring predictive molecules of acute adverse events in response to volumetric‑modulated arc therapy for prostate cancer using urinary metabolites;Molecular and Clinical Oncology;2024-07-09

2. Metabolomics for searching validated biomarkers in cancer studies: a decade in review;Expert Review of Molecular Diagnostics;2024-06-21

3. Plasma metabolomics and lipidomics reveal potential novel biomarkers in early gastric cancer: An explorative study;The International Journal of Biological Markers;2024-06-11

4. Matrix- and Surface-Assisted Laser Desorption/Ionization Mass Spectrometry Methods for Urological Cancer Biomarker Discovery—Metabolomics and Lipidomics Approaches;Metabolites;2024-03-20

5. Clinical advances in analytical profiling of signature lipids: implications for severe non-communicable and neurodegenerative diseases;Metabolomics;2024-03-08